Emerging Infectious Diseases That Threaten the Blood Supply

Mungai, 2001, Transfusion-transmitted malaria in the United States from 1963 through 1999, N Engl J Med, 344, 1973, 10.1056/NEJM200106283442603 Leiby, 2006, Babesiosis and blood transfusion: flying under the radar, Vox Sang, 90, 157, 10.1111/j.1423-0410.2006.00740.x Krause, 2000, Atovaquone and azithromycin for the treatment of babesiosis, N Engl J Med, 343, 1454, 10.1056/NEJM200011163432004 Leiby, 2002, Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors, Transfusion, 42, 1585, 10.1046/j.1537-2995.2002.00251.x 2002, Chagas disease after organ transplantation—United States, 2001, MMWR Morb Mortal Wkly Rep, 51, 210 Wendel, 1998, Transfusion-transmitted Chagas’ disease, Curr Opin Hematol, 5, 406, 10.1097/00062752-199811000-00009 Leiby, 2002, Trypanosoma cruzi in Los Angeles and Miami blood donors: Impact of evolving donor demographics on seroprevalence and implications for transfusion transmission, Transfusion, 42, 549, 10.1046/j.1537-2995.2002.00077.x Biggerstaff, 2003, Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002, Transfusion, 43, 1007, 10.1046/j.1537-2995.2003.00480.x Pealer, 2003, Transmission of West Nile virus through blood transfusion in the United States in 2002, N Engl J Med, 349, 1236, 10.1056/NEJMoa030969 Stramer, 2005, West Nile virus among blood donors in the United States, 2003 and 2004, N Engl J Med, 353, 451, 10.1056/NEJMoa044333 Young, 2004, Parvovirus B19, N Engl J Med, 350, 586, 10.1056/NEJMra030840 Anderson, 1985, Experimental parvoviral infection in humans, J Infect Dis, 152, 257, 10.1093/infdis/152.2.257 Brown, 2001, Parvovirus B19: Implications for transfusion medicine, Transfusion, 41, 130, 10.1046/j.1537-2995.2001.41010130.x Azzi, 1999, The transfusion-associated transmission of parvovirus B19, Transfus Med Rev, 13, 194, 10.1016/S0887-7963(99)80033-9 Pellett, 2003, Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors, Transfusion, 43, 1260, 10.1046/j.1537-2995.2003.00490.x Dodd, 2005, Human herpesvirus-8: What (not) to do?, Transfusion, 45, 463, 10.1111/j.0041-1132.2005.05008.x Hladik, 2006, Transmission of human herpesvirus 8 by blood transfusion, N Engl J Med, 355, 1331, 10.1056/NEJMoa055009 Hien, 2004, Avian influenza—A challenge to global health care structures, N Engl J Med, 351, 2363, 10.1056/NEJMp048267 Ungchusak, 2005, Probable person-to-person transmission of avian influenza A (H5N1), N Engl J Med, 352, 333, 10.1056/NEJMoa044021 Katz, 1999, Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts, J Infect Dis, 180, 1763, 10.1086/315137 Chotpitayasunondh, 2005, Human disease from influenza A (H5N1), Thailand, 2004, Emerg Infect Dis, 11, 201, 10.3201/eid1102.041061 2005, Writing Committee of the World Health Organization Consultation on Human Influenza A/H5: Avian influenza A (H5N1) infections in humans, N Engl J Med, 353, 1374 Llewelyn, 2004, Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion, Lancet, 363, 417, 10.1016/S0140-6736(04)15486-X Peden, 2004, Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient, Lancet, 364, 527, 10.1016/S0140-6736(04)16811-6 Hilton, 2004, Prevalence of lymphoreticular prion protein accumulation in UK tissue samples, J Pathol, 203, 733, 10.1002/path.1580 Sowemimo-Coker, 2006, Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates, Vox Sang, 90, 265, 10.1111/j.1423-0410.2006.00765.x Gregori, 2006, Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands, Transfusion, 46, 1152, 10.1111/j.1537-2995.2006.00865.x Boneva, 2002, Simian foamy virus infection in a blood donor, Transfusion, 42, 886, 10.1046/j.1537-2995.2002.00134.x Alter, 2003, New viruses and their relationship to hepatitis, 35 Slichter, 2006, Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia, Transfusion, 46, 731, 10.1111/j.1537-2995.2006.00791.x Ruane, 2004, Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light, Transfusion, 44, 877, 10.1111/j.1537-2995.2004.03355.x AuBuchon, 2005, Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction, Transfusion, 45, 1335, 10.1111/j.1537-2995.2005.00202.x Pelletier, 2006, Pathogen inactivation techniques, Best Pract Res Clin Haematol, 19, 205, 10.1016/j.beha.2005.04.001